|
Volumn 31, Issue 5, 1999, Pages 2079-2083
|
Myocardial protection for transplantation
a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
AZATHIOPRINE;
CARDIOPLEGIC AGENT;
CELSIOR;
CYCLOSPORIN;
HTK SOLUTION;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
OKT 3;
THYMOCYTE ANTIBODY;
UNCLASSIFIED DRUG;
UNIVERSITY OF WISCONSIN SOLUTION;
ADULT;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DONOR;
FEMALE;
GRAFT FAILURE;
GRAFT REJECTION;
GRAFT SURVIVAL;
HEART MUSCLE ISCHEMIA;
HEART PRESERVATION;
HEART PROTECTION;
HEART TRANSPLANTATION;
HEMODYNAMICS;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
REPERFUSION INJURY;
ADENOSINE;
ADULT;
ALLOPURINOL;
DISACCHARIDES;
ELECTROLYTES;
FEMALE;
GLUCOSE;
GLUTAMATES;
GLUTATHIONE;
HEART;
HEART TRANSPLANTATION;
HEMODYNAMIC PROCESSES;
HISTIDINE;
HUMANS;
INSULIN;
MALE;
MANNITOL;
MIDDLE AGED;
MYOCARDIUM;
ORGAN PRESERVATION;
ORGAN PRESERVATION SOLUTIONS;
POTASSIUM CHLORIDE;
PROCAINE;
RAFFINOSE;
|
EID: 0032801072
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(99)00269-9 Document Type: Article |
Times cited : (26)
|
References (14)
|